QuidelOrtho Completes Acquisition of LEX Diagnostics and Molecular Testing Platform
The $100 million deal brings an ultra-fast system for respiratory viruses to QuidelOrtho’s point-of-care portfolio.
The $100 million deal brings an ultra-fast system for respiratory viruses to QuidelOrtho’s point-of-care portfolio.
The FDA has cleared Labcorp’s rapid fentanyl urine test, which detects norfentanyl and delivers results in 10 minutes for use in CLIA-certified labs, according to the company’s press release.
The study will analyze three key proteins to determine if blood-based biomarkers can provide an earlier and more accessible diagnostic method.
Cenevo has launched the Labguru Customer Portal, a digital platform that integrates with ELN and LIMS systems to centralize workflows and provide real-time project visibility for CROs, CDMOs, and diagnostic labs.
Research indicates that apolipoprotein B testing outperforms standard LDL cholesterol tests in predicting risk and guiding therapy.